- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Do | reAlpha Tech Corp.: reAlpha to Host Live X Spaces Fireside Chat on Real-World AI Applications in Mortgage and Real Estate | ||
| Do | Postal Realty Trust, Inc. Provides Fourth Quarter and Full Year 2025 Update | ||
| Do | Enact Holdings, Inc.: Enact to Host Fourth Quarter 2025 Earnings Call February 4th | ||
| Do | BGIN BLOCKCHAIN LIMITED Announces Share Purchases by Chairman and Independent Director | ||
| Do | Nasdaq, Inc.: Nasdaq Reports December 2025 Volumes and 4Q25 Statistics | ||
| Do | MEDIROM Healthcare Technologies Inc.: World, Co-founded by Sam Altman and Alex Blania, Accelerates Expansion in Japan via MEDIROM Collaboration Re.Ra.Ku's "Orb" Authentication Surpasses 20,000 Cumulative Verifications, Doubling in Approximately ... | ||
| Do | Kite Realty Group Trust: Kite Realty Group to Report Fourth Quarter 2025 Financial Results on February 17, 2026 | ||
| Do | TransUnion's 2026 Mortgage Pricing Goes Live - Prioritizing Lower Costs for Homebuyers | ||
| Do | Cemtrex Inc.: Cemtrex Completes Acquisition of Invocon, Launches Aerospace & Defense Segment and Expands Participation in Missile Defense Modernization | ||
| Do | National Bank Holdings Corporation Announces Date for 2025 Fourth Quarter and Full Year Earnings Release | ||
| Do | Septerna, Inc.: Septerna Expands Leadership with Appointment of Industry Veteran Mark A. Wilson as Chief Legal Officer | ||
| Do | Resmed, Inc.: Resmed to Report Second Quarter Fiscal 2026 Earnings on January 29, 2026 | ||
| Do | Spyre Therapeutics, Inc.: Spyre Therapeutics Announces Grants of Inducement Awards | ||
| Do | The Vita Coco Company Appoints Shelley Broader to Board of Directors | ||
| Do | Beyond Oil Ltd.: Beyond Oil Continues its Commercial Expansion in the United States Market | ||
| Do | Merit Medical Systems, Inc.: Merit Medical Appoints F. Ann Millner as Chair of the Board and Announces Projected Preliminary Unaudited Revenue Results for the Fourth Quarter of 2025 | ||
| Do | Itron, Inc.: Itron to Announce Fourth Quarter and Full Year 2025 Results on Feb. 17, 2026 | ||
| Do | Tilray Brands, Inc.: Tilray Brands Delivers Record Q2 Fiscal 2026 Net Revenue of $218 Million, Moves to Net Cash Position and Reaffirms Full-Year Adjusted EBITDA Guidance | ||
| Do | Eledon Pharmaceuticals, Inc.: Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook | ||
| Do | Treace Medical Concepts, Inc.: Treace Announces First Surgical Case Utilizing Lapiplasty Lightning Technology | ||
| Do | ImmuCell Corporation: ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 | ||
| Do | Beta Bionics, Inc.: Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics | ||
| Do | Senseonics Holdings, Inc.: Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist Automated Insulin Delivery (AID) System | ||
| Do | Vaxart, Inc.: Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 | ||
| Do | Krystal Biotech, Inc.: Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of Patients with Cystic Fibrosis |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .